| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |